(CRPGF) / CA: (CND.CN) Starting To Trend
CBD’s have taken the spotlight recently with companies and consumers searching for different delivery methods. From sleep to energy, X-Sprays proprietary CBD infused product line is focused on areas that have huge market demand. (CRPGF) recently signed a letter of intent to acquire X-Sprays, which offers a product line of life-enhancement products that are administered through a sublingual oral spray delivery system. (CRPGF) via X-Sprays, is also moving toward smokeless marijuana products containing THC in the near future. If you have yet to look at this Early Alert, read below for full details.
Tetra Bio-Pharma Inc. (TBPMF) Announces Approval to List on the TSX Venture Exchange
Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (CSE:TBP) (TSX-V:TBP) (OTCQB:TBPMF), today announced that its common shares have been approved for trading on the TSX Venture Exchange and that it has applied for voluntary delisting of its common shares from the Canadian Securities Exchange (CSE). Tetra’s shares will commence trading on the TSX Venture on the opening of markets on Wednesday, August 16, 2017, under the symbol “TBP”.
GT Biopharma (OXIS) Hits New Highs! Conf. Call Today
GT Biopharma (OXIS) made another move higher on Tuesday (8-15). This time it broke above $0.10..nearly to $0.11 with its high of $0.108. This marked a total run of 355.7%. After multiple announcements on key milestones over the last few weeks, today (8-16) the company will be hosting a conference call after the closing bell. The call will start promptly at 4:15pm EST on Wednesday, August 16, 2017. The dial in number for the call is 712-775-7031. Meeting ID number is 576-591-822.